Patents-Review.com
🔗 Permalink
Assignee profile:

MAP PHARMACEUTICALS, INC.

City:

Irvine, California

Country:

United States

Published Applications:

21

Last publication date:

2017-07-13

Patent Grants:

19

Last grant date:

2019-01-08

Top Inventors for applications by MAP PHARMACEUTICALS, INC.

These are the the leading inventors for applications assigned to MAP PHARMACEUTICALS, INC.:

Recent patent applications by MAP PHARMACEUTICALS, INC.

MAP PHARMACEUTICALS, INC. based in Irvine, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2017-07-13 ✅ Patent 10,172,853 granted on 2019-01-08
US20170196861A1
Human necessities

Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile

 #2 | 2016-05-12 ✅ Patent 9,610,415 granted on 2017-04-04
US20160129208A1
Human necessities

Enhanced eductor design

 #3 | 2016-04-21 ✅ Patent 9,833,451 granted on 2017-12-05
US20160106669A1
Human necessities

Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile

 #4 | 2015-12-24 ✅ Patent 9,365,591 granted on 2016-06-14
US20150368275A1
Chemistry; metallurgy

Fluoroergoline analogs

 #5 | 2015-04-09 ✅ Patent 9,150,593 granted on 2015-10-06
US20150099755A1
Chemistry; metallurgy

Fluoroergoline analogs

 #6 | 2014-07-10
US20140194435A1
Chemistry; metallurgy

NOVEL SUBSTITUTED INDOLO 4,3 FG QUINOLINES USEFUL FOR TREATING MIGRAINE

 #7 | 2014-07-10
US20140194434A1
Chemistry; metallurgy

NOVEL SUBSTITUTED INDOLO 4,3 FG QUINOLINES USEFUL FOR TREATING MIGRAINE

 #8 | 2014-06-26 ✅ Patent 8,895,743 granted on 2014-11-25
US20140179730A1
Chemistry; metallurgy

Methysergide derivatives

 #9 | 2014-06-26 ✅ Patent 9,394,314 granted on 2016-07-19
US20140179704A1
Chemistry; metallurgy

8′-hydroxy-dihydroergotamine compounds and compositions

 #10 | 2014-05-08 ✅ Patent 9,480,803 granted on 2016-11-01
US20140123975A1
Human necessities

Dose counter with lockout mechanism

 #11 | 2014-04-03 ✅ Patent 8,969,374 granted on 2015-03-03
US20140094483A1
Chemistry; metallurgy

Iso-ergoline derivatives

 #12 | 2014-03-13 ✅ Patent 8,841,448 granted on 2014-09-23
US20140073790A1
Chemistry; metallurgy

Fluoroergoline analogs

 #13 | 2014-03-13 ✅ Patent 8,933,093 granted on 2015-01-13
US20140073647A1
Chemistry; metallurgy

Fluoroergoline analogs

 #14 | 2014-02-06 ✅ Patent 8,722,699 granted on 2014-05-13
US20140039188A1
Chemistry; metallurgy

Iso-ergoline derivatives

 #15 | 2014-01-23 ✅ Patent 9,161,912 granted on 2015-10-20
US20140023595A1
Human necessities

Inhalation devices and related methods for administration of sedative hypnotic compounds

 #16 | 2013-12-26 ✅ Patent 9,012,640 granted on 2015-04-21
US20130345253A1
Human necessities

Cabergoline derivatives

 #17 | 2013-11-21 ✅ Patent 9,216,259 granted on 2015-12-22
US20130306061A1
Human necessities

Methods and apparatus for delivering aerosolized medication

 #18 | 2013-06-27 ✅ Patent 8,946,420 granted on 2015-02-03
US20130165469A1
Chemistry; metallurgy

Neuromodulatory compounds

 #19 | 2011-06-30 ✅ Patent 9,227,030 granted on 2016-01-05
US20110155129A1
Human necessities

Enhanced eductor design

 #20 | 2011-06-23 ✅ Patent 8,710,092 granted on 2014-04-29
US20110152280A1
Chemistry; metallurgy

Substituted indolo 4,3 FG quinolines useful for treating migraine

 #21 | 2011-01-27 ✅ Patent 8,720,433 granted on 2014-05-13
US20110017210A1
Human necessities

Dose counter with lockout mechanism

Also check out MAP Pharmaceuticals, Inc.'s (Irvine, United States) applicant profile with 6 patent applications submitted.

AssigneeID:

63661 ⎘